GIM
GSK icon

Glenmede Investment Management’s GSK GSK Stock Holding History

Glenmede Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.22M Sell
51,478
-4,978
-9% -$194K 0.01% 541
2025
Q2 		$2.17M Buy
+56,456
New +$2.16M 0.01% 551

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Glenmede Investment Management's GSK Position: Q3 2025 in Review

Glenmede Investment Management reduced its GSK (GSK) stake by 8.8% in Q3 2025, selling an estimated $194K and leaving 51,478 shares worth $2.22M. The position accounts for 0.01% of the portfolio, ranked #541.

Glenmede Investment Management first reported a position in GSK in Q2 2025 and has held it in 2 quarters since. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • Glenmede Investment Management held 51,478 shares of GSK worth $2.22M as of Q3 2025.
  • Glenmede Investment Management sold 4,978 GSK shares in Q3 2025, an estimated $194K.
  • GSK made up 0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #541 holding.
  • Glenmede Investment Management first reported a position in GSK in Q2 2025 and has held it in 2 quarters since.
  • 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.